ArticleJMIR public health and surveillance2026
Prevalence and Factors Associated With Acute Stress Disorder Among Adults Ever Infected With COVID-19 During the Ending Phase of the Pandemic in 7 Chinese Cities: Cross-Sectional Study.
Article in JMIR public health and surveillance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute stress disorder (ASD) among people ever infected with COVID-19 is prevalent and may lead to posttraumatic stress disorder. Soon after China relaxed their COVID-19 control measures in November 2022 or December 2022, the infection rate surged rapidly, creating huge uncertainty and stressful situations. Little is known about situations regarding ASD at the ending phase of the pandemic. Objective: The study aimed to investigate the potential of personal cognitive or emotional factors and environmental factors of ASD. Methods: A cross-sectional study was conducted among 5545 people ever infected with COVID-19 aged 18-60 years from December 27, 2022, to January 9, 2023, living in 7 cities of China. The 5-item Chinese version of the Primary Care PTSD Screen was used to assess ASD. Multiple logistic regression analyses were performed to identify factors of ASD. Results: The prevalence of ASD was 21.2% (1174/5545). Adjusted for the background variables, significant personal risk factors (COVID-19 infection severity, cognitions including perceived high reinfection risk and perceived weak acquired natural immunity, and emotions including worry about the long-term physical harms and panic about infection of older or younger family members), and significant environmental risk factors (difficulties in getting information and medical supplies, having unvaccinated older or younger family members, and having significant others with severe COVID-19 symptoms) were identified. Conclusions: The prevalence of ASD among people ever infected with COVID-19 was noticeable. It is warranted to identify those at high risk of developing ASD and provide them with care and early interventions to prevent deterioration. Such programs may consider targeting the modifiable risk factors found in this study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.